The ENHANCE Phase 3b clinical trial is evaluating the safety and efficacy of a modified treatment regimen of Briumvi for ...

Successfully Completed IPO on NYSE American, Paving the Way for Accelerated Growth Capital Deployment Focused on Infrastructure, Technology, and ...